Table 2.
Characteristics of infections
| All infections (n = 312) | Severe infections∗ (n = 185) | |
|---|---|---|
| Patients with min. 1 infection | 134 (29%) | 91 (20%) |
| Site of infection | ||
| Pulmonary, n | 106 (34%) | 79 (43%) |
| Urinary tract, n | 57 (18%) | 15 (8%) |
| Skin, n | 29 (9%) | 10 (5%) |
| Sepsis, n | 25 (8%) | 25 (14%) |
| Gastrointestinal tract, n | 22 (7%) | 14 (8%) |
| SBP, n | 11 (4%) | 11 (6%) |
| Other, n | 45 (14%) | 21 (11%) |
| Unknown, n | 17 (5%) | 10 (5%) |
| Type of infection | ||
| Bacterial | 128 (41%) | 79 (43%) |
| Viral | 9 (3%) | 4 (2%) |
| Fungal | 6 (2%) | 2 (1%) |
| Unknown (not cultured) | 169 (54%) | 100 (54%) |
| Treatment | ||
| No treatment | 8 (3%) | 0 |
| Intravenous treatment | 183 (59%) | 171 (92%) |
| Peroral treatment | 120 (38%) | 14 (8%) |
| Agent known | 149 | 83 |
| Escherichia coli | 45 (30%) | 25 (30%) |
| Other gram-neg. rods | 21 (14%) | 15 (18%) |
| Staphylococcus species | 27 (18%) | 15 (18%) |
| Streptococcus species | 13 (9%) | 8 (10%) |
| Other/including virus + fungus | 31/43 (21%/29%) | 16/20 (19%/24%) |
| Resistance detected, yes | 74 (50%) | 50 (60%) |
| Infection when hospitalized, yes | 243 (78%) | 182 (98%) |
∗
Infections were characterized as severe infections when demanding in-hospital treatment, if treated with intravenous antibiotics and/or if supportive treatment was necessary as a result of the infection.